Clinical trials
Stem Cell clinical trials
Below are recruiting stem cell clinical trials, each written for real people, not researchers. We’re tracking 743 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07469592Recruiting
Mindfulness and music therapy for stem cell transplant patients
This trial tests a combined mindfulness and music therapy program delivered through an app or website. It aims to help patients cope with the stress of stem cell transplant for blood cancers like leukemia or lymphoma.
Miami, FloridaAges 18 years+ - NCT05068674RecruitingPhase 1
Stem cell heart muscle therapy for weak heart after prior heart attack
This Phase 1 study tests a treatment made from stem cells to grow heart muscle cells (“cardiomyocytes”) for people with long-lasting (chronic) heart weakness after a prior heart attack. It aims to see if the therapy can improve heart function and is safe in carefully selected patients.
Palo Alto, CaliforniaAges 21–80 - NCT03357172Recruiting
Study immune changes after a stem cell transplant
This study looks at how the immune system changes after an allogeneic stem cell transplant (using a donor’s stem cells). It may help researchers understand what controls immune recovery and transplant-related complications.
Vandœuvre-lès-NancyAges 18 years+ - NCT07227883RecruitingEarly Phase 1
Secretome injections for facial rejuvenation
This early-phase trial tests whether injections of a substance called secretome can improve facial aging by reducing wrinkles and improving skin elasticity and texture. Participants receive multiple injections over several visits and must be willing to follow a strict skincare routine and avoid other cosmetic procedures during the study.
Newport Beach, CaliforniaAges 30–75 - NCT07692841RecruitingPhase 3
One dose vs two doses of G-CSF for stem cell donors
This trial compares giving a single dose of G-CSF versus splitting it into two doses to see which works better for collecting stem cells from healthy bone marrow donors. The goal is to find a simpler and possibly more comfortable way to help donors produce enough stem cells for transplant.
Changsha, HunanAges 18–65 - NCT02641769RecruitingPhase 1/Phase 2
Stem cell injection into testicles for infertility
This trial tests whether injecting your own stem cells into your testicles can help your body start producing sperm. It is for men whose infertility is caused by a sperm-making problem rather than a blockage.
Amman, Amman GovernorateAges 21–50 - NCT07362810RecruitingPhase 2
Adding IL-11 to G-CSF for faster blood cell recovery after transplant
This trial tests whether adding a second drug (IL-11) to the standard G-CSF can help your blood cells recover faster after a stem cell transplant using your own cells. It is for people with multiple myeloma or lymphoma who are about to have this transplant.
Zhengzhou, HenanAges 18–70 - NCT04357600Enrolling by invitationPhase 1/Phase 2
Stem cell treatment for hepatitis B–related cirrhosis
This early-stage trial tests umbilical cord “mesenchymal” stem cells in people with liver scarring (cirrhosis) that is caused by hepatitis B. It may help improve liver function and related complications, but it is mainly designed to check safety and how well the treatment works.
Jakarta, DKI JakartaAges 18–65 - NCT07107165Recruiting
Support for stem cell transplant patients and caregivers
This study tests a program to help stem cell transplant patients and their family caregivers cope with the stress of treatment. If you are getting a stem cell transplant at the University of Pittsburgh and have a caregiver who can join, you may be able to take part.
Pittsburgh, PennsylvaniaAges 18 years+ - NCT03779854RecruitingPhase 2
Preventing graft-versus-host disease in kids after stem cell transplant
This trial tests whether removing certain immune cells (T cells) from the donor transplant can lower the risk of chronic graft-versus-host disease (long-term immune attack after transplant) in children and young adults with blood cancers. If you qualify, it may help improve transplant outcomes while tracking safety and side effects.
Los Angeles, CaliforniaAges 6 months–26 years - NCT03383081RecruitingPhase 2
Stem cell injection for moderate knee osteoarthritis pain
This Phase 2 study tests whether injected umbilical-cord stem cells can improve safety and reduce symptoms in people with moderate knee osteoarthritis. It focuses on people with significant knee pain who have not gotten enough relief from standard, non-procedure treatments.
Changsha, HunanAges Up to 70 years - NCT05436418RecruitingPhase 1/Phase 2
Lower-dose transplant medicines to prevent graft-versus-host disease
This early-phase study tests a lower dose of cyclophosphamide given after a stem cell transplant to prevent graft-versus-host disease (GVHD). It also uses sirolimus and mycophenolate to improve how well the donor immune system accepts the transplant, aiming to reduce side effects while keeping protection against GVHD.
Duarte, CaliforniaAges 12–120 - NCT06028828RecruitingPhase 2
Adapted conditioning for stem cell transplant
This trial tests a risk-adapted conditioning regimen (chemotherapy and/or radiation given before transplant) for people with certain blood cancers or bone marrow disorders who need a stem cell transplant from a donor. The goal is to tailor the conditioning strength to each patient’s risk, which may help improve outcomes and reduce side effects.
Orange, CaliforniaAges 18–70 - NCT06059391RecruitingPhase 2
Vaccine for stem cell donors to prevent CMV
This trial tests whether giving a CMV vaccine to stem cell donors can help protect recipients from CMV infection after transplant. It is for adults with specific blood cancers who are CMV-positive and have a matched related donor.
Duarte, CaliforniaAges 18–75 - NCT06564740Recruiting
Stem cell therapy for infants with biliary atresia and cirrhosis
This study is testing whether stem cells can help infants with liver cirrhosis from biliary atresia (a blocked bile duct condition) who have already had Kasai surgery. It aims to see if stem cell therapy can improve liver function and reduce complications.
Istanbul, IstanbulAges 2 months–18 years - NCT06605508Recruiting
Stem cell injection for erectile dysfunction
This trial tests whether injecting stem cells or their byproducts can help men with erectile dysfunction who haven't responded well to standard treatments like Viagra. It aims to find a new option for improving sexual function.
Dubai, DubaiAges 30–75 - NCT06727721RecruitingPhase 2
Stem cell therapy for hard-to-treat type 2 diabetes
This trial tests a new stem cell treatment for people with type 2 diabetes that is difficult to control with standard medications. The treatment uses a special kind of stem cell to try to improve blood sugar levels.
ShanghaiAges 18–70 - NCT06951074RecruitingPhase 2/Phase 3
Stem cell transplant for type 1 diabetes
This trial tests whether transplanting stem cells that can turn into insulin-producing cells helps people with type 1 diabetes manage their blood sugar. It may reduce the need for insulin injections.
CairoAges 15–18 - NCT07127705Recruiting
How stem cells and immune cells respond to a supplement
This trial tests how a supplement affects your stem cells and immune cells over time. It may help researchers understand if the supplement supports your body's natural defenses.
Klamath Falls, OregonAges 18–75 - NCT07252050RecruitingPhase 1/Phase 2
Ruxolitinib and half-matched transplant for severe sickle cell disease
This trial tests a new approach using the drug ruxolitinib to help a half-matched bone marrow transplant work better for people with severe sickle cell disease. It aims to reduce complications and improve outcomes.
Aurora, ColoradoAges 12–45 - NCT07253129Recruiting
Stem cell transplant study for T-cell lymphoma patients with partial response
This study compares two types of stem cell transplants (from a donor or your own cells) for people with certain T-cell lymphomas who had only a partial response to first chemotherapy. It aims to see which approach may work better.
Shanghai, Shanghai MunicipalityAges 18–70 - NCT07396155RecruitingPhase 1/Phase 2
Stem cell therapy for diabetic kidney disease
This trial tests whether stem cells from donated umbilical cords can safely help people with type 2 diabetes who also have kidney damage. It aims to see if this therapy can improve kidney function.
YogyakartaAges 30–65 - NCT06692868Recruiting
Fertility protection for young cancer patients
This trial offers fertility preservation options for children, teens, and young adults diagnosed with cancer or undergoing stem cell transplant before age 21, to help protect their ability to have biological children in the future.
Ulm, Baden-WurttembergAges Any age - NCT06802406Recruiting
Nutrition support for transplant or cell therapy patients
This study tests a program to help patients who are getting a transplant or cell therapy and have trouble getting enough food. It provides nutrition resources to improve their health during treatment.
Stanford, CaliforniaAges 8–80
Hear when a new Stem Cell trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for stem cell?
- Yes. Clin2 currently lists 743 recruiting stem cell studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a stem cell trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a stem cell trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.